<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50211">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01829529</url>
  </required_header>
  <id_info>
    <org_study_id>2013-000405-23</org_study_id>
    <nct_id>NCT01829529</nct_id>
  </id_info>
  <brief_title>Antibiotic Prophylaxis - Amoxicillin</brief_title>
  <official_title>Susceptibility Changes Among Oral Microorganisms Following Single Dose Antibiotic Prophylaxis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bodil Lund</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <authority>Sweden: Medical Products Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of the present study is that quantitative and qualitative oral microflora
      alterations and changes in antibiotic susceptibility among oral commensal microflora will
      occur following a single dose administration of amoxicillin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 33 healthy volunteers, 16 males and 17 females, will be included. Written
      informed consent will be obtained from all participants.

      Subjects will be excluded if they have taken antibiotics within the previous three months,
      are pregnant, breast-feeding or allergic against penicillin.

      The participants will be given a single dose of 2 g amoxicillin. Saliva samples will be
      collected before administration of antibiotics (day 1) and on day 2, 5, 10, 17 and 24.
      Un-stimulated saliva will be accumulated in a plastic container. Concentration of
      amoxicillin in saliva will be measured on day 1, 2 and 5. Samples will be used for the
      determination of antibiotic concentration. Analyses of the sensitivities to amoxicillin and
      some other clinically relevant antibiotic compounds will also be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Quantitative and qualitative changes in the oral microflora will be determined as well as changes is susceptibility to amoxicillin among these commensals.</measure>
    <time_frame>Day 1, 2, 5, 10, 17 and 24</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration of amoxicillin in saliva after one dose administration of amoxicillin</measure>
    <time_frame>Day 1, 2, 5</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">33</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Amoxicillin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects receive one dose of 2 g Amoxicillin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin</intervention_name>
    <description>Amoxicillin</description>
    <arm_group_label>Amoxicillin</arm_group_label>
    <other_name>Amoxicillin, Sandoz, 1 g tablet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Healthy

          -  Age 18-45

          -  Understands the study procedure and speaks Swedish and/or English

        Exclusion Criteria:

          -  Treatment with antibiotics within the previous three months

          -  Pregnant

          -  Breast-feeding

          -  Allergic against penicillin

          -  Concomitantly participate in another medical product study

          -  Treatment with any kind of medication, health food preparations or probiotics
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margareta Hultin, Dentist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dental Medicine, Karolinska Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bodil Lund, Dentist</last_name>
    <phone>+46 8 585 839 55</phone>
    <email>bodil.lund@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margareta Hultin, Dentist</last_name>
    <email>margareta.hultin@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karolinska University Hospital. Department of Dental Medicine</name>
      <address>
        <city>Stockholm</city>
        <state>Huddinge</state>
        <zip>SE-141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bodil Lund, DDS, ass prof</last_name>
      <phone>+46 8 585 839 55</phone>
      <email>bodil.lund@ki.se</email>
    </contact>
    <contact_backup>
      <last_name>Margareta Hultin, DDS, Phd</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 20, 2013</lastchanged_date>
  <firstreceived_date>April 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Bodil Lund</investigator_full_name>
    <investigator_title>Assoc. professor, Dentist</investigator_title>
  </responsible_party>
  <keyword>Antibiotic prophylaxis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
